未登录

F

Farshad Mirzavi

cardiovascular diseases research center

H指数:15

被引数:805

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Synergistic effects of Tschimgine combined with 5-Fluorouracil against HT-29 human colorectal cancer cells

Tschimgine与5-氟尿嘧啶联合应用对HT-29人结直肠癌细胞的协同效应

BMC Complementary Medicine and Therapies

IF3.4

2026-08-110

OA

Combined effects of honey and silver nanoparticles on wound healing in human dermal fibroblast cells

蜂蜜和银纳米粒子的联合效应对人真皮成纤维细胞伤口愈合的影响

BMC Complementary Medicine and Therapies

IF3.4

2025-12-290

OAAI

Puerarin as a multifaceted anticancer agent: Mechanisms, targets, and therapeutic potential across multiple cancers

葛根素作为一种多面抗肿瘤剂：机制、靶点及在多种癌症中的治疗潜力

Chinese Herbal Medicines

IF8.9

2025-11-040

OAAI

A Comprehensive Insight Into the Roles of Exosomal circRNAs in Metabolic Syndrome

IF5

2025-11-010

PRE

Development of nano-liposomal platelet-poor plasma (PPP) for topical application in wound healing and burn treatment

纳米脂质体血小板贫血浆（PPP）用于伤口愈合和烧伤治疗的局部应用开发

Journal of Pharmaceutical Investigation

IF5.1

2025-06-100

PRE

Ultrasound-assisted efficient targeting of doxorubicin to the tumor microenvironment by lyso-thermosensitive liposomes of varying phase transition temperatures

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF4.7

2025-03-010

OA

Recent advances with erythrocytes as therapeutics carriers

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2024-11-011

PRE

The protection role of human growth hormone on skin cells following ultraviolet B exposure

JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY

IF3.7

2024-08-010

PRE

The potential protective role of carotenoids from saffron: A focus on endoplasmic reticulum stress-related organ damage

FOOD SCIENCE & NUTRITION

IF3.8

2024-06-211

OA

Anticancer Effects of Beta-Cyclodextrin-Graphene Oxide Nanoparticles Loaded with Selenium on Human Malignant Glioblastoma Cells

载硒 β-环糊精-氧化石墨烯纳米粒子对人恶性胶质母细胞瘤细胞的抗癌作用

IF3.2

2024-03-061

PRE

Nanoparticles-based therapeutics for the management of bacterial infections: A special emphasis on FDA approved products and clinical trials

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES

IF4.7

2023-09-0139

OA

The in vitro anti-cancer synergy of neurokinin-1 receptor antagonist, aprepitant, and 5-aminolevulinic acid in glioblastoma

IF5

2023-04-249

OAAI

Gold-containing liposomes and glucose-coated gold nanoparticles enhances the radiosensitivity of B16F0 melanoma cells via increasing apoptosis and ROS production

IF5.1

2023-04-0115

PRE

The neuropeptide substance P/neurokinin-1 receptor system and diabetes: From mechanism to therapy

神经肽p物质/neurokinin-1受体系统与糖尿病: 从机制到治疗

IF5

2023-01-184

PRE

Inhibition of glioblastoma proliferation, invasion, and migration by Urolithin B through inducing G0/G1 arrest and targeting MMP-2/-9 expression and activity

尿石素B通过诱导G0/G1阻滞和靶向MMP-2/-9表达和活性抑制胶质母细胞瘤增殖、侵袭和迁移

IF5

2022-10-3015

PRE

A review of PD-1/PD-L1 siRNA delivery systems in immune T cells and cancer cells

免疫T细胞和癌细胞中PD-1/PD-L1 siRNA递送系统的研究进展

INTERNATIONAL IMMUNOPHARMACOLOGY

IF4.7

2022-10-0113

PRE

Punica granatum peel supplementation attenuates cognitive deficits and brain injury in rat by targeting the Nrf2-HO-1 pathway

FOOD SCIENCE & NUTRITION

IF3.8

2022-09-129

OA

CD73 downregulation by EGFR-targeted liposomal CD73 siRNA potentiates antitumor effect of liposomal doxorubicin in 4T1 tumor-bearing mice

SCIENTIFIC REPORTS

IF3.9

2022-06-219

OAAI

Pegylated liposomal encapsulation improves the antitumor efficacy of combretastatin A4 in murine 4T1 triple-negative breast cancer model

INTERNATIONAL JOURNAL OF PHARMACEUTICS

IF5.2

2022-02-0130

PRE

Enhanced antitumor immune response in melanoma tumor model by anti-PD-1 small interference RNA encapsulated in nanoliposomes

CANCER GENE THERAPY

IF5

2021-08-0218

PREAI